SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Ellis P Ron

(Last) (First) (Middle)
3000 KENT AVENUE, SUITE A1-100

(Street)
WEST LAFAYETTE IN 47906

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/04/2011
3. Issuer Name and Ticker or Trading Symbol
ENDOCYTE INC [ ECYT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 13,142 D
Common Stock 68,279 D(1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) (2) 08/08/2011 Common Stock 14 $0.19 D
Stock Option (right to buy) (2) 02/07/2012 Common Stock 6,998 $0.19 D
Stock Option (right to buy) (2) 02/10/2015 Common Stock 13,089 $1.91 D
Stock Option (right to buy) (2) 02/17/2016 Common Stock 26,178 $1.91 D
Stock Option (right to buy) (2) 08/31/2016 Common Stock 77,793 $1.91 D
Stock Option (right to buy) (3) 05/31/2017 Common Stock 52,356 $2.1 D
Stock Option (right to buy) (4) 02/12/2018 Common Stock 65,445 $3.06 D
Stock Option (right to buy) (5) 03/05/2019 Common Stock 108,438 $2.54 D
Stock Option (right to buy) (6) 02/11/2020 Common Stock 143,979 $3.82 D
Series A-1 Convertible Preferred Stock (7) (8) Common Stock 7,853 (7) D(1)
Explanation of Responses:
1. The reported securities are owned directly by P. Ron Ellis and Margaret Heard Ellis, JTWROS.
2. The option is fully vested and immediately exercisable.
3. Shares subject to the option vest as follows: 4,363 shares vest on May 31, 2007; 1,090 shares vest on each of June 30, 2007 and July 31, 2007; 5,453 shares vest on January 1, 2008 and the remaining 40,357 shares vest monthly over a period of 48 months beginning on January 31, 2008.
4. Shares subject to the option vest monthly over a period of 48 months beginning on February 29, 2008.
5. Shares subject to the option vest monthly over a period of 48 months beginning on March 31, 2009.
6. Shares subject to the option vest monthly over a period of 48 months beginning on February 28, 2010.
7. The reported securities are convertible at any time at the option of the reporting person, but automatically convert into shares of Common Stock on a 1-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
8. Not applicable.
Remarks:
/s/ P. Ron Ellis 01/31/2011
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.